Co-Authors
This is a "connection" page, showing publications co-authored by Fabrizio D'Ascenzo and Giuseppe Biondi-Zoccai.
Connection Strength
3.195
-
Percutaneous coronary intervention or coronary artery bypass graft in left main coronary artery disease: a comprehensive meta-analysis of adjusted observational studies and randomized controlled trials. J Cardiovasc Med (Hagerstown). 2018 Oct; 19(10):554-563.
Score: 0.788
-
Network meta-analysis of studies comparing closure devices for femoral access after percutaneous coronary intervention. J Cardiovasc Med (Hagerstown). 2018 Oct; 19(10):586-596.
Score: 0.197
-
Intracoronary versus intravenous adenosine to assess fractional flow reserve: a systematic review and meta-analysis. J Cardiovasc Med (Hagerstown). 2018 Jun; 19(6):274-283.
Score: 0.193
-
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 Study. J Invasive Cardiol. 2018 08; 30(8):283-288.
Score: 0.192
-
The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): A randomized controlled trial. Int J Cardiol. 2018 04 15; 257:1-6.
Score: 0.191
-
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients. Eur Heart J. 2017 Nov 07; 38(42):3160-3172.
Score: 0.185
-
Optical coherence tomography compared with fractional flow reserve guided approach in acute coronary syndromes: A propensity matched analysis. Int J Cardiol. 2017 Oct 01; 244:54-58.
Score: 0.180
-
High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC study. Cardiol J. 2017; 24(2):139-150.
Score: 0.177
-
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study). Am J Cardiol. 2017 Apr 01; 119(7):978-982.
Score: 0.175
-
Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial. Int J Cardiol. 2013 Oct 03; 168(3):1739-44.
Score: 0.138
-
COVID-19 in Europe: the Italian lesson. Lancet. 2020 04 04; 395(10230):1110-1111.
Score: 0.109
-
Excess all-cause mortality during COVID-19 outbreak: potential role of untreated cardiovascular disease. Minerva Cardioangiol. 2020 Sep 30.
Score: 0.057
-
Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med. 2020 Jun 02; 9(6).
Score: 0.055
-
Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (COVID-19). J Cardiovasc Pharmacol. 2020 05; 75(5):359-367.
Score: 0.055
-
Safety of intermediate left main stenosis revascularization deferral based on fractional flow reserve and intravascular ultrasound: A systematic review and meta-regression including 908 deferred left main stenosis from 12 studies. Int J Cardiol. 2018 Nov 15; 271:42-48.
Score: 0.050
-
Meta-Analysis Comparing Outcomes of Drug Eluting Stents Versus Single and Multiarterial Coronary Artery Bypass Grafting. Am J Cardiol. 2018 12 15; 122(12):2018-2025.
Score: 0.049
-
Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]. Int J Cardiol. 2018 07 15; 263:188.
Score: 0.049
-
Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis. Kardiol Pol. 2018; 76(2):440-451.
Score: 0.047
-
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study. Int J Cardiol. 2018 Jan 01; 250:80-85.
Score: 0.046
-
What is the optimal treatment for symptomatic patients with isolated coronary myocardial bridge? A systematic review and pooled analysis. J Cardiovasc Med (Hagerstown). 2017 Oct; 18(10):758-770.
Score: 0.046
-
Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis. Med Sci Monit Basic Res. 2017 May 12; 23:179-222.
Score: 0.045
-
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents. Am J Cardiol. 2017 07 01; 120(1):33-39.
Score: 0.044
-
Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review. Med Sci Monit Basic Res. 2017 Mar 17; 23:58-86.
Score: 0.044
-
Impact of an optical coherence tomography guided approach in acute coronary syndromes: A propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):E46-E52.
Score: 0.044
-
Sixty-day readmission rate after percutaneous coronary intervention: predictors and impact on long-term outcomes. Eur Heart J Qual Care Clin Outcomes. 2015 Nov 01; 1(2):79-84.
Score: 0.040